The tiny protein known as transthyretin can cause big problems in the body when it misfolds after secretion. While healthy ...

Alzheimer's disease is likely caused by stalled protein processing in the brain, according to a new study. The research, ...

These insights could drive the development of new drugs to treat transthyretin amyloidosis, a progressive and fatal disease.

New research uncovers how declining protein clearance mechanisms with age lead to Alzheimer’s, Parkinson’s, and other ...

Groundbreaking study uncovers the crucial link between REM sleep patterns and Alzheimer's disease, providing new insights for ...

Insights into the structures could lead to improved treatment strategies for transthyretin amyloidosis, a progressive, fatal disease in men.

Exercise may positively influence the interactions between brain cells in the hippocampus, a brain region involved in ...

Able to cross the blood-brain barrier, Xenon gas seemed to perk the mice right up, which began to become particularly active ...

Researchers demonstrated that individuals who had childhood epilepsy have an increased accumulation of brain amyloid later in life, potentially predisposing them to late-onset brain amyloid disorders, ...

The U.S. Food and Drug Administration has approved monthly maintenance dosing for Japan's Eisai and partner Biogen's ...

Researchers from Mainz University and EMBL Hamburg present a new approach to determine the form of disordered proteins by ...

Drugs targeting amyloid plaques have failed to show efficacy in clinical trials. A new approach is needed to tackle AD ...